SOLV
Solventum Corp.
NYSE: SOLV · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$66.49
-1.51% today
Updated 2026-04-29
Market cap
$11.54B
P/E ratio
7.49
P/S ratio
1.39x
EPS (TTM)
$8.88
Dividend yield
—
52W range
$62 – $88
Volume
1.3M
Solventum Corp. (SOLV) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $2.03B | $2.20B | $1.68B | $1.92B | $1.19B | $369.00M |
| Capital expenditures | $271.00M | $277.00M | $251.00M | $290.00M | $380.00M | $379.00M |
| Depreciation | $599.00M | $597.00M | $578.00M | $561.00M | $555.00M | — |
| Stock-based comp | $35.00M | $38.00M | $37.00M | $39.00M | $112.00M | $161.00M |
| Free cash flow | $1.75B | $1.93B | $1.43B | $1.63B | $805.00M | $-10.00M |
| Investing cash flow | $228.00M | $-278.00M | $-253.00M | $-230.00M | $-380.00M | — |
| Financing cash flow | $-2.21B | $-1.96B | $-1.46B | $-1.55B | $-240.00M | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |